Fingolimod Lauryl Sulfate

FDA Drug Profile — TASCENSO ODT

Drug Details

Generic Name
Fingolimod Lauryl Sulfate
Brand Names
TASCENSO ODT
Application Number
NDA214962
Sponsor
CATALENT U.K. SWINDON ZYDIS LIMITED
NDC Codes
4
Dosage Forms
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients
FINGOLIMOD LAURYL SULFATE

Indications and Usage

1 INDICATIONS AND USAGE TASCENSO ODT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. TASCENSO ODT is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )